Can the Food You Eat Rewire Your Genes? The MicroRNA Controversy Dividing Scientists

Every meal you eat delivers more than calories, vitamins, and fiber. According to a sweeping new review published in Frontiers in Nutrition, your food may also carry microscopic RNA molecules capable of surviving digestion, crossing into your body, and potentially switching human genes on or off. The idea sounds like science fiction, yet it has fueled more than a decade of fierce debate. Now, a team of researchers from Tecnologico de Monterrey, Chettinad Academy of Research and Education, and the University of Oslo has weighed the evidence for and against so-called dietary exogenous microRNAs, and their verdict is nuanced: the molecules are real, they can survive the journey through the gut, and they may locally influence intestinal health, but claims of dramatic cross-kingdom gene regulation remain far from proven.

MicroRNAs, or miRNAs, are tiny single-stranded RNA molecules roughly 20 to 24 nucleotides long. They do not code for proteins. Instead, they act as molecular dimmer switches, binding to complementary sequences on messenger RNAs and dampening the production of the proteins those messages encode. Nearly every living organism uses them: mammals, plants, even viruses and parasites deploy miRNAs to fine-tune their biology. What makes the dietary story so provocative is the suggestion that miRNAs made by a plant or a cow could, after being swallowed, silence genes inside a human cell. The field ignited in 2012 when researchers reported that miR168a, abundant in rice, could bind to a human and mouse gene called LDLRAP1 in the liver and impair cholesterol clearance. That single study launched a thousand follow-ups, and a thousand arguments.

The central technical problem is survival. RNA is notoriously fragile; digestive enzymes called RNases, stomach acid, and cooking heat should shred it. Yet plant miRNAs carry a chemical shield: a 2′-O-methyl group at their 3′ end that blocks degradation pathways such as uridylation and truncation. Even more importantly, many dietary miRNAs travel packaged inside extracellular vesicles, nanoscale membrane bubbles typically 40 to 100 nanometers across, sometimes reaching 400 nanometers, that are shed by cells of edible plants like ginger, garlic, broccoli, apple, watermelon, and tea. These vesicles are built from proteins, lipids, sugars, and nucleic acids, with plant vesicles rich in phosphatidic acid and galactolipids. Their negative surface charge and heterogeneous composition help them withstand cooking and simulated digestion, and they have been detected in the feces of humans and animals after miRNA-rich meals.

The proposed route through the body reads like a smuggling operation. Vesicle-encapsulated miRNAs ride through the stomach, encounter the acidic, enzyme-filled environment of the intestine, and then interact with the epithelial cells lining the gut wall, with immune cells lurking beneath, and with the trillions of microbes in the lumen. Intestinal cells appear to swallow these particles through caveolin-mediated endocytosis and macropinocytosis, while gut bacteria may take them up through lipid-mediated selection. A small fraction might even reach the bloodstream, though circulating dietary miRNAs have been only minimally documented. The rest passes out of the body in feces, where researchers keep finding plant miRNAs such as miR-156e, miR-159, and miR-162 after acute plant-based meals, but notably not in serum.

Laboratory studies have produced striking results. Ginger-derived exosome-like nanoparticles applied to inflamed intestinal cells reduced the expression of inflammatory mediators including NF-κB, IL-6, IL-8, and TNF-α, and shifted macrophages from a pro-inflammatory M1 state toward a healing M2 profile. A luciferase reporter assay confirmed that ginger miR-164d directly targets the gene Tab1, with NF-κB as a downstream effector, and synthetic miR-164d-enriched vesicles fed to colitis mice reduced inflammatory cell infiltration and restored epithelial architecture. Garlic-derived vesicles carrying miR-3630-5p suppressed the TLR4-MyD88-NF-κB cascade and restored tight junction proteins ZO-1, claudin-1, and occludin, effectively re-sealing the intestinal barrier. Tea vesicles reprogrammed macrophages through miR-166d-5p and miR-396a-3p binding to IKBKB and AKT1. Soybean miR-159a, validated by dual-luciferase assays, suppressed the TCF7-MYC axis of the Wnt/β-catenin pathway and reduced tumor incidence in colorectal carcinogenesis mouse models. Apple nanoparticles modulated the intestinal transporter OATP2B1 through multiple miRNAs acting together with the AGO2 protein complex.

The microbiota angle may be the most surprising frontier. Broccoli-derived miR-159 fed to mice increased beneficial genera including Bifidobacterium, Blautia, and Bacteroides, and in bacterial coculture it directly targeted bacterial genes CelC, RnY, and PhaZ2. Garlic exosomes boosted Lachnospiraceae and the homeostasis-essential commensal Bacteroides thetaiotaomicron while suppressing Helicobacter and Escherichia-Shigella. Centella asiatica vesicles reduced pathogenic species such as Salmonella enterica and Klebsiella pneumoniae. Even breast milk enters the picture: a study of lactating women found that maternal diet shaped the miRNA profile of milk, and those milk miRNAs correlated with the composition of the infant gut microbiome, hinting at a vertical molecular dialogue between mother and child.

So why the controversy? Skeptics point to a stubborn pattern: fecal detection rarely translates into quantifiable serum levels, and a large meta-analysis spanning 133 miRNAs from seven independent studies concluded that transfer of dietary miRNAs into host tissues does not occur under all conditions, with expression levels generally too low to regulate host transcripts. Critics attribute positive findings to experimental artifacts, contamination, small sample sizes, and poorly optimized bioinformatic pipelines. There is also a deeper methodological trap: many studies administer intact extracellular vesicles rather than purified miRNAs, so any observed benefit could come from the vesicles’ lipids, proteins, or other cargo rather than the RNA itself. And the doses used in cell culture and gavage experiments often exceed anything achievable by eating a normal meal, establishing biological plausibility rather than demonstrated dietary effect.

The review’s authors draw a careful line. Current evidence, they conclude, provides stronger support for local gastrointestinal effects than for widespread systemic regulation after dietary exposure. Detection of a miRNA in food, feces, or tissue does not by itself prove functional gene regulation. The strongest mechanistic evidence clusters around intestinal development and epithelial barrier integrity, where yak milk miR-34a helped epithelial cells survive hypoxic stress and sow milk miR-146a-5p activated the Wnt pathway to lengthen intestinal villi in offspring. Inflammatory signaling modulation through NF-κB emerges as the second most consistent theme across independent studies. But whether these effects occur at physiologically relevant doses, through ordinary eating rather than engineered delivery, remains an open question.

What would settle the debate? The researchers call for physiologically relevant dosing, rigorous miRNA-specific loss-of-function experiments such as depletion and rescue strategies, direct target validation in living organisms, standardized analytical methods, and controlled human interventions, which are currently almost entirely absent from the literature. The only human data available are correlational, such as the observation that rice-derived miR-168 appears in gastric tissue biopsies across gastritis and cancer stages, with a trend toward better prognosis in patients with higher levels, a finding that hints at biomarker potential but proves nothing causal. Meanwhile, proponents argue that engineered plant exosomes, synthetic nanocarriers, and microbial delivery vehicles could overcome absorption barriers, though scalability, safety, and standardization remain unsolved.

Whether dietary miRNAs ultimately become a new class of oral therapeutics for colitis, inflammatory bowel disease, and colorectal cancer, or fade as a fascinating artifact, the field is advancing the way good science always does: through replication, skepticism, and increasingly sophisticated tools spanning transcriptomics, systems biology, and microbiology. For now, the molecules in your broccoli and your morning milk are neither miracle gene regulators nor inert debris. They are survivors, demonstrably resilient travelers of the digestive tract, whose true influence on human health is still being measured one carefully controlled experiment at a time.

Subject of Research: Biological effects and mechanistic evidence for dietary exogenous microRNAs in gastrointestinal health and cross-kingdom gene regulation

Article Title: Dietary exogenous microRNAs in the gut: biological effects, mechanistic evidence, and controversies

Article References: Méndez-García, A., García-Mendoza, M. A., Pérez-Martínez, P., Figueroa-Ramírez, M., Banerjee, A., Pathak, S., Duttaroy, A. K., & Paul, S. (2026). Dietary exogenous microRNAs in the gut: biological effects, mechanistic evidence, and controversies. Frontiers in Nutrition, 13, Article 1974997. https://doi.org/10.3389/fnut.2026.1974997

Image Credits: AI Generated

DOI: 10.3389/fnut.2026.1974997

Keywords: microRNAs, dietary miRNAs, extracellular vesicles, gut microbiota, cross-kingdom regulation, intestinal barrier, inflammation, colitis, plant-derived miRNAs, milk exosomes, gene regulation, gastrointestinal health